共查询到20条相似文献,搜索用时 31 毫秒
1.
2.
3.
Role for the p53 homologue p73 in E2F-1-induced apoptosis 总被引:20,自引:0,他引:20
Irwin M Marin MC Phillips AC Seelan RS Smith DI Liu W Flores ER Tsai KY Jacks T Vousden KH Kaelin WG 《Nature》2000,407(6804):645-648
4.
5.
NIE Jing LIU Lin ZHAO XiaoHang XIE Ping ZHOU PingKun XING GuiChun LIU XiangJun HE FuChu HAN WeiDong * & ZHANG LingQiang * Department of Molecular Biology General Hospital of Chinese People’s Liberation Army Beijing China State Key Laboratory of Proteomics Beijing Proteome Research Center Beijing Institute of Radiation Medicine Beijing Department of General Surgery Chi... 《科学通报(英文版)》2011,(30)
The tumor suppressor p53 locates at the key point of cell growth or apoptosis balance, and the expression level of p53 is tightly controlled by ubiquitin ligases including MDM2. Upon DNA damage stresses, p53 was accumulated and activated, leading to cell cycle arrest or apoptosis. We previously showed that Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by interacting with and stabilizing MDM2, and consequently enhancing MDM2-mediated ubiquitylation of p53. However, it is uncle... 相似文献
6.
7.
8.
Amplification of a gene encoding a p53-associated protein in human sarcomas. 总被引:106,自引:0,他引:106
Despite extensive data linking mutations in the p53 gene to human tumorigenesis, little is known about the cellular regulators and mediators of p53 function. MDM2 is a strong candidate for one such cellular protein; the MDM2 gene was originally identified by virtue of its amplification in a spontaneously transformed derivative of mouse BALB/c cells and the MDM2 protein subsequently shown to bind to p53 in rat cells transfected with p53 genes. To determine whether MDM2 plays a role in human cancer, we have cloned the human MDM2 gene. Here we show that recombinant-derived human MDM2 protein binds human p53 in vitro, and we use MDM2 clones to localize the human MDM2 gene to chromosome 12q13-14. Because this chromosomal position appears to be altered in many sarcomas, we looked for changes in human MDM2 in such cancers. The gene was amplified in over a third of 47 sarcomas, including common bone and soft tissue forms. These results are consistent with the hypothesis that MDM2 binds to p53, and that amplification of MDM2 in sarcomas leads to escape from p53-regulated growth control. This mechanism of tumorigenesis parallels that for virally-induced tumours, in which viral oncogene products bind to and functionally inactivate p53. 相似文献
9.
Jing Nie Lin Liu XiaoHang Zhao Ping Xie PingKun Zhou GuiChun Xing XiangJun Liu FuChu He WeiDong Han LingQiang Zhang 《科学通报(英文版)》2011,56(30):3155-3161
The tumor suppressor p53 locates at the key point of cell growth or apoptosis balance, and the expression level of p53 is
tightly controlled by ubiquitin ligases including MDM2. Upon DNA damage stresses, p53 was accumulated and activated, leading
to cell cycle arrest or apoptosis. We previously showed that Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes
p53 degradation by interacting with and stabilizing MDM2, and consequently enhancing MDM2-mediated ubiquitylation of p53.
However, it is unclear how the Smurf1-MDM2 interaction is regulated in response to DNA damage stress. Here, we show that in
response to etoposide treatment Smurf1 dissociates from MDM2, resulting in MDM2 destabilization and p53 accumulation. The
negative regulation of Smurf1 on apoptosis is released. Notably, this dissociation is a slow process rather than a rapid response,
implicating high expression of Smurf1 might confer the resistance against p53 activation. Consistent with this notion, we
observed that Smurf1/2 ligases are highly expressed in colon cancer, esophageal squamous cell carcinoma and pancreatic cancer
tissues, suggesting the oncogenic tendency of Smurf1/2. 相似文献
10.
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage 总被引:18,自引:0,他引:18
Tanaka H Arakawa H Yamaguchi T Shiraishi K Fukuda S Matsui K Takei Y Nakamura Y 《Nature》2000,404(6773):42-49
The p53 gene is frequently inactivated in human cancers. Here we have isolated a p53-inducible gene, p53R2, by using differential display to examine messenger RNAs in a cancer-derived human cell line carrying a highly regulated wild-type p53 expression system. p53R2 contains a p53-binding sequence in intron 1 and encodes a 351-amino-acid peptide with striking similarity to the ribonucleotide reductase small subunit (R2), which is important in DNA synthesis during cell division. Expression of p53R2, but not R2, was induced by ultraviolet and gamma-irradiation and adriamycin treatment in a wild-type p53-dependent manner. Induction of p53R2 in p53-deficient cells caused G2/M arrest and prevented cells from death in response to adriamycin. Inhibition of endogenous p53R2 expression in cells that have an intact p53-dependent DNA damage checkpoint reduced ribonucleotide reductase activity, DNA repair and cell survival after exposure to various genotoxins. Our results indicate that p53R2 encodes a ribonucleotide reductase that is directly involved in the p53 checkpoint for repair of damaged DNA. The discovery of p53R2 clarifies a relationship between a ribonucleotide reductase activity involved in repair of damaged DNA and tumour suppression by p53. 相似文献
11.
12.
应用PCRSSCP技术及DNA 测序技术对37 例原发性脑肿瘤及相应外周血淋巴细胞中p53 基因5 ~8 外显子的突变情况进行了检测,结果表明,p53 基因在原发性脑肿瘤中的突变频率为19 % (7/37) .并且突变频率在不同病理类别脑肿瘤中的分布是非随机的,其中星形细胞肿瘤中的突变频率最高,为36 % (5/14) .所有突变均为错义点突变,57 % (4/7) 的突变位于CpG位点.突变仅发现于脑组织中,外周血淋巴细胞中未检出突变,这些结果提示,p53 基因突变在脑肿瘤的发生发展过程中起一定的作用,p53 基因在散发性脑肿瘤中的突变为体细胞型的突变 相似文献
13.
14.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation 总被引:1,自引:0,他引:1
Zheng H Ying H Yan H Kimmelman AC Hiller DJ Chen AJ Perry SR Tonon G Chu GC Ding Z Stommel JM Dunn KL Wiedemeyer R You MJ Brennan C Wang YA Ligon KL Wong WH Chin L DePinho RA 《Nature》2008,455(7216):1129-1133
15.
Suppression of lung adenocarcinoma progression by Nkx2-1 总被引:1,自引:0,他引:1
Winslow MM Dayton TL Verhaak RG Kim-Kiselak C Snyder EL Feldser DM Hubbard DD DuPage MJ Whittaker CA Hoersch S Yoon S Crowley D Bronson RT Chiang DY Meyerson M Jacks T 《Nature》2011,473(7345):101-104
16.
Cytoplasmic polyadenylation-induced translation controls germ cell development, neuronal synaptic plasticity and cellular senescence, a tumour-suppressor mechanism that limits the replicative lifespan of cells. The cytoplasmic polyadenylation element binding protein (CPEB) promotes polyadenylation by nucleating a group of factors including defective in germline development 2 (Gld2), a non-canonical poly(A) polymerase, on specific messenger RNA (mRNA) 3' untranslated regions (UTRs). Because CPEB regulation of p53 mRNA polyadenylation/translation is necessary for cellular senescence in primary human diploid fibroblasts, we surmised that Gld2 would be the enzyme responsible for poly(A) addition. Here we show that depletion of Gld2 surprisingly promotes rather than inhibits p53 mRNA polyadenylation/translation, induces premature senescence and enhances the stability of CPEB mRNA. The CPEB 3' UTR contains two miR-122 binding sites, which when deleted, elevate mRNA translation, as does an antagomir of miR-122. Although miR-122 is thought to be liver specific, it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-canonical poly(A) polymerase, was found to regulate p53 mRNA polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4. 相似文献
17.
Mutations in the p53 gene occur in diverse human tumour types 总被引:196,自引:0,他引:196
J M Nigro S J Baker A C Preisinger J M Jessup R Hostetter K Cleary S H Bigner N Davidson S Baylin P Devilee 《Nature》1989,342(6250):705-708
The p53 gene has been a constant source of fascination since its discovery nearly a decade ago. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes. Moreover, in human tumours, the short arm of chromosome 17 is often deleted. In colorectal cancers, the smallest common region of deletion is centred at 17p13.1; this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies. 相似文献
18.
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions 总被引:5,自引:0,他引:5
Gorgoulis VG Vassiliou LV Karakaidos P Zacharatos P Kotsinas A Liloglou T Venere M Ditullio RA Kastrinakis NG Levy B Kletsas D Yoneta A Herlyn M Kittas C Halazonetis TD 《Nature》2005,434(7035):907-913
DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive. We analysed a panel of human lung hyperplasias, all of which retained wild-type p53 genes and had no signs of gross chromosomal instability, and found signs of a DNA damage response, including histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding protein 1 (53BP1) and apoptosis. Progression to carcinoma was associated with p53 or 53BP1 inactivation and decreased apoptosis. A DNA damage response was also observed in dysplastic nevi and in human skin xenografts, in which hyperplasia was induced by overexpression of growth factors. Both lung and experimentally-induced skin hyperplasias showed allelic imbalance at loci that are prone to DNA double-strand break formation when DNA replication is compromised (common fragile sites). We propose that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations. 相似文献
19.
20.
为了筛选可以恢复肿瘤细胞中p53功能的小分子,作者用表达野生型p53的人类直肠癌细胞HCT116建立了一株能够应答激活p53信号通路的荧光素酶报告基因的稳定细胞系,同时用表达野生型p53的人类骨肉瘤细胞U2-OS建立了一株能够应答激活p53信号通路的mCherry红色荧光蛋白报告基因的稳定细胞系.为了检测筛选p53靶向药物的有效性,利用三种已知的以p53为靶点的小分子药物(cisplatin,doxorubicin以及Nutlin-3)处理这两种稳定细胞系,结果显示p53信号通路在这两个稳定细胞系中均能够被激活.为了探索小分子RNA作为恢复p53功能的靶标药物,并进一步验证这两种细胞模型用于药物筛选的可行性,分别检测了MDM2和MDMX的5个不同shRNA.通过比较HCT116稳定细胞的荧光素酶活性和U2-OS稳定细胞中荧光蛋白的荧光强度,我们筛选出了有效沉默MDM2或MDMX的shRNA.数据表明,这两种细胞模型不仅可用作筛选激活p53的小分子化合物的平台,而且可用于筛选激活p53信号通路的小分子RNA. 相似文献